Cargando…
Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step
Anti-viral small molecules are currently lacking for treating coronavirus infection. The long development timescales for such drugs are a major problem, but could be shortened by repurposing existing drugs. We therefore screened a small library of FDA-approved compounds for potential severe acute re...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619434/ https://www.ncbi.nlm.nih.gov/pubmed/34835112 http://dx.doi.org/10.3390/v13112306 |